Aricept

Type: Product
Name: Aricept
First reported Sep 16 2014 - Updated 23 hours ago - 2 reports

AstraZeneca teams up with rival Lilly for Alzheimer’s

AstraZeneca and US rival Lilly have signed an agreement to develop a new and experimental pill for the treatment of Alzheimer’s.The two companies will develop and commercialise AZD3293, an oral beta secretase cleaving enzyme (also known as a BACE inhibitor) ... [Published Pharmafocus - Sep 16 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 3 reports

Alirocumab (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

FOR IMMEDIATE RELEASE, Illinois – United States – September 16,2014 (PR Buzz): The PCSK9 field is flush with new mAbs. In its current state, it expects that alirocumab will be the second-to-market PCSK9, following Amgen’s PCSK9 mAb, evolocumab. It anticipates ... [Published Stock Nod - Sep 16 2014]
First reported Sep 10 2014 - Updated Sep 11 2014 - 1 reports

Study: Late-stage dementia patients get medications with little to no benefit

Los Angeles — More than half of nursing home patients who suffer severe dementia and are likely to die within a year or two are administered medications that offer little to no benefit and may cause pointless discomfort, a new study finds.The latest research, ... [Published Detroit News - Sep 10 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 1 reports

We Shouldn't Have to Pay Doctors to Talk

I oppose Futile Care Theory–aka medical futility–because it authorizes the unilateral withholding of wanted efficacious treatment.What is efficacious? A proper understanding would be treatment that accomplished its purpose. Hence, a ventilator facilitates ... [Published National Review - Sep 10 2014]
First reported Sep 01 2014 - Updated Sep 01 2014 - 1 reports

University of Arizona testing experimental Alzheimer's drug

The University of Arizona is recruiting people with mild to moderate Alzheimer’s disease to be part of a national clinical research study.The UA is one of 50 locations participating in a new clinical study of people with Alzheimer’s who are already being ... [Published Arizona Daily Star - Sep 01 2014]
First reported Aug 31 2014 - Updated Aug 31 2014 - 1 reports

Wanted: Alzheimer's disease pioneers

T-817MA is an experimental drug shown to protect rats’ brain cells from the memory-stealing effects of Alzheimer’s disease. Will it do the same for humans?That’s the question researchers in San Diego and across the nation hope to answer by recruiting ... [Published U-T San Diego - Aug 31 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 1 reports

Is mother's cold intolerance part of dementia?

Dear Dr. Roach: My mother was diagnosed with Alzheimer’s disease in 2009, and she is taking Namenda and Aricept to help slow the advancement of the disease.I am writing because she complains of being cold all the time. She and my father keep the temperature ... [Published Detroit News - Aug 29 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Alzheimer's drug study seeks volunteers from area

NEW HAVEN >> There are drugs that slow the progression of Alzheimer’s disease, but none is available to prevent or halt its terrifying effects on the brain.However, a nationwide clinical study is investigating a medication that researchers hope ... [Published New Haven Register - Aug 27 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

Someone Check Her Aricept Levels

Benen captures a Noonan classic : More than a week after Texas Gov. Rick Perry (R) was indicted on two felony counts, the Wall Street Journal’s Peggy Noonan shared her concerns about the case on national television yesterday. The exchange was one ... [Published Balloon Juice - Aug 25 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

Investigational therapy focuses on slowing progression in mild to moderate Alzheimer's -- ScienceDaily

Patients with mild to moderate Alzheimer's disease currently have no treatment options to slow brain cell deterioration. Researchers at Houston Methodist's Nantz National Alzheimer Center are studying an investigational drug that proposes to do just ... [Published DailyMe.Com - Aug 21 2014]
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

Investigational Therapy Focuses on Slowing Progression in Mild to Moderate Alzheimer's

’s Nantz National Alzheimer Center only Texas site to offer this study Contact InformationAvailable for logged-in reporters onlyNewswise — Patients with mild to moderate Alzheimer’s disease currently have no treatment options to slow brain cell deterioration. ... [Published Newswise - Aug 20 2014]
First reported Aug 18 2014 - Updated Aug 18 2014 - 2 reports

Struggling Eisai files its thyroid cancer drug lenvatinib in U.S., EU

Still suffering from the loss of patent protection on its big Alzheimer's drug Aricept, Japan's Eisai today said that the company had fired off a pair of applications for its new cancer drug to U.S. as well as European regulators.Eisai is seeking to gain ... [Published FierceBiotech - Aug 18 2014]

Quotes

"For me the bottom line is how can you improve your response to stress?" says Alvord, a member of the American Psychological Association and adjunct associate professor at George Washington University School of Medicine and...
Pearlstein quizzed the group again, asking: "What one little pill is the best treatment for vascular dementia?" He said it comes in 81 mg. and should be taken daily. The answer: Aspirin
...with dementia along with their families and caregivers," said Christopher U Missling, PhD, President and Chief Executive Officer of Anavex.   "Early screening is an important step for treatment.  To that end, we are very pleased to be joining together with the Alzheimer's Foundation to offer the community a memory screening room at the conference."

More Content

All (39) | News (34) | Reports (0) | Blogs (4) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Alirocumab (Acute Coronary Syndrome) - Forecast... [Published Stock Nod - Sep 16 2014]
Zontivity (Acute Coronary Syndrome) - Forecast ... [Published Stock Nod - Sep 16 2014]
AstraZeneca teams up with rival Lilly for Alzhe... [Published Pharmafocus - Sep 16 2014]
Brilinta Market (Acute Coronary Syndrome) Marke... [Published MyNewsDesk - Sep 16 2014]
UPDATE 1-AstraZeneca gets up to $500 mln from L... [Published CNBC - Sep 16 2014]
Sleeping pills give you Alzheimer's? As a major... [Published Mail Online UK - Sep 16 2014]
Brilinta (Acute Coronary Syndrome) - Forecast a... [Published Individual.com - Sep 15 2014]
Is Stress Giving You Alzheimer's? [Published NewsMax.com - Sep 15 2014]
Alzheimer's support group hears dementia expert [Published Lebanon Daily News - Sep 13 2014]
Study: Late-stage dementia patients get medicat... [Published Detroit News - Sep 10 2014]
We Shouldn't Have to Pay Doctors to Talk [Published National Review - Sep 10 2014]
Anavex Supports Alzheimer's Foundation of Ameri... [Published SPi World News - Sep 08 2014]
No predictor test – and no cure [Published Keep Me Current - Sep 03 2014]
Anavex to Present at Rodman & Renshaw 16th Annu... [Published Wall Street Business Network - Sep 03 2014]
University of Arizona testing experimental Alzh... [Published Arizona Daily Star - Sep 01 2014]
Wanted: Alzheimer's disease pioneers [Published U-T San Diego - Aug 31 2014]
Is mother's cold intolerance part of dementia? [Published Detroit News - Aug 29 2014]
Alzheimer's drug study seeks volunteers from area [Published New Haven Register - Aug 27 2014]
Anavex Selects The Alfred Hospital in Melbourne... [Published CW 50 Detroit - Aug 26 2014]
Someone Check Her Aricept Levels [Published Balloon Juice - Aug 25 2014]
Huperzine: Advanced Herbal Support for Memory a... [Published Nutrition Review - Aug 21 2014]
Investigational therapy focuses on slowing prog... [Published DailyMe.Com - Aug 21 2014]
Investigational Therapy Focuses on Slowing Prog... [Published Newswise - Aug 20 2014]
Struggling Eisai files its thyroid cancer drug ... [Published FierceBiotech - Aug 18 2014]
Eisai files for US and EU approval of lenvatini... [Published Pharma Letter - Aug 18 2014]
Anger as four surgeries refuse to give out Alzh... [Published Congleton Guardian - Aug 14 2014]
Q&A session with Warrington's top doc [Published Warrington Guardian - Aug 13 2014]
Anavex Reports Fiscal Third Quarter 2014 Financ... [Published Good Day Sacramento - Aug 13 2014]
Health Column: Treating Alzheimer’s dementia wi... [Published Glenwood Independent - Aug 11 2014]
My dad; death, dementia and ducklings [Published Herald Scotland - Aug 11 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Someone Check Her Aricept Levels [Published Balloon Juice - Aug 25 2014]
Benen captures a Noonan classic : More than a week after Texas Gov. Rick Perry (R) was indicted on two felony counts, the Wall Street Journal’s Peggy Noonan shared her concerns about the case on national television yesterday. The exchange was one ...
newbie [Published HealthBoards - Jun 13 2014]
Hello,I'm new to the boards. My mom has dementia and has been on aricept and namenda for over 8 years. She has been sundowning for the past year, getting very agitated and talking to people who have been dead over fifty years. She stays with me at ...
A Look at Pfizer’s Recent Financial Performance [Published Wall St. Cheat Sheet - May 15 2014]
Pfizer ( NYSE:PFE ) is getting a lot of attention lately, mostly given its potential deal with AstraZeneca ( NYSE:AZN ). This topic has been thoroughly covered lately. But despite the drama surrounding the headlines of late, Pfizer is still my ...
Chase Pharmaceuticals Corporation inks $21 mln ... [Published PE Hub Blog - May 12 2014]
Chase Pharmaceuticals Corporation has raised a $21 million Series B financing led by New Rhein Healthcare Investors . Other new investors include Edmond de Rothschild Investment Partners and Cipla Ventures , the new venture capital arm of Cipla ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.